NewsRx

Search our medical news database

Industry News/Investment

Funds Received for Development of Cell Production System

Published in Gene Therapy Weekly, June 19th, 1995

Aastrom Biosciences, Inc., Ann Arbor, Michigan, announced that it has received $10 million from two companion private placements of equity.

Proceeds of the financing will support further development of the Aastrom Cell Production System (CPS), a proprietary, automated device that utilizes Aastrom's novel ex vivo stem and progenitor blood cell production technology.

Development milestones include further clinical trials in North America and Europe to assess the clinical efficacy of hematopoietic stem and progenitor cells produced by the Aastrom CPS. These "Ideal Transplant Cells" are intended to enhance patient recovery from immunosuppressive effects...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook